Platelet Transfusions

New Approaches to Old Topic Programs
  • 56 Pages
  • 1.89 MB
  • English
S Karger Pub
Haematology, Pharmacology, Hematology, Me
The Physical Object
ID Numbers
Open LibraryOL12930979M
ISBN 103805568681
ISBN 139783805568685

Platelet transfusions are indicated in patients with clinically significant bleeding attributable to thrombocytopenia or abnormal platelet function. Alternatively, prophylactic Platelet Transfusions book transfusions may benefit severely thrombocytopenic patients in whom even small amounts of hemorrhage may be life-threatening (eg, in the central nervous system).

Platelets. Book • Fourth Edition • Platelet transfusion is the standard of care in patients with platelet disorders when conservative measures have failed or are not appropriate.

However, patients may become platelet immunized (auto- or allo-) and refractory to platelet transfusions. This chapter will describe recombinant factor.

Platelets, Fourth Edition, integrates the entire field of platelet biology, pathophysiology, and clinical medicine with contributions from world experts from 18 award-winning reference provides clear presentations by basic scientists on the cellular, molecular, and genetic mechanisms of platelets and the role of platelets in thrombosis, hemorrhage, inflammation Price: $   Give prophylactic platelet transfusions (platelet transfusions to patients who do not have clinically significant bleeding [WHO grade 0 or 1] and do not require a procedure) to patients with reversible bone marrow failure receiving intensive chemotherapy or undergoing allogeneic HSCT to maintain Platelet Transfusions book platelet count at or above 10 × 10 9 /l (1B)Cited by: A no-prophylaxis platelet transfusion strategy for hematologic malignancies.

NEJM al Lancet. Variability in effectiveness of prophylactic platelet transfusions Difference in proportions and 95% Confidence Intervals 0 10 20 30 40 All patients AutoHSCT sub-groupFile Size: KB.

Platelets - winner of a Highly Commended BMA Medical Book Award for Internal Medicine - is the definitive current source of state-of-the-art knowledge about platelets and covers the entire field of platelet biology, pathophysiology, and clinical medicine.

Download Platelet Transfusions FB2

Recently there has been a rapid expansion of knowledge in both basic biology and the clinical approach to platelet-related diseases. Blood transfusion remains a life-saving therapy and according to World Health Organization (WHO) guidelines, of 10 units per population, approximately 8 million units of blood are currently needed to meet the transfusion demand for a population of about million [].While in the industrialized world, blood provision and blood safety are well established, in Africa, there is limited Author: John Ayodele Olaniyi.

Platelet transfusion in rare congenital platelet disorders such as Bernard-Soulier syndrome, Glanzmann's thrombasthenia, thrombocytopenia with absent radii (TAR), Wiskott-Aldrich syndrome, Fanconi anaemia, amegakaryocytic thrombocytopenia can provoke the development of multi-specific HLA or platelet specific antibodies and they should be used.

° Rh negative platelets may be given to Rh negative patients if plentiful; References: 1) Valsami S, Dimitroulis D, Gialeraki A, Chimonidou M, Politou M, Current trends in platelet transfusions practice: The role of ABO-RhD and human leukocyte antigen incompatibility.

Asian Journal of Transfusion Science ; 9(2)   Occurs ~ days after transfusion of platelets or packed RBCs; Abrupt fall in platelets to platelet transfusion; Investigation Diagnosis supported by anti-HLA allo-antibodies in patient's serum.

Treatment IV immunoglobulin and/or steroids should be considered early. Platelets are classically used in the clinic to maintain hemostasis, while recent evidence has shown the important role for platelets in the host inflammatory and immune responses.

In fact, platelets in vivo produce different mediators such as cytokines or chemokines, which may be involved in the course of disease treatment, thus platelets transfusion is often an effective therapy in many by: 1.

Dr Klein has published widely, authoring or co-authoring more than publications, including journal articles and book chapters on transfusion medicine in major textbooks on haematology, internal medicine, and blood banking. He is on the editorial boards of Transfusion and Transfusion Medicine Reviews.

Purpose To provide evidence-based guidance on the use of platelet transfusion in people with cancer.

This guideline updates and replaces the previous ASCO platelet transfusion guideline published initially in Methods ASCO convened an Expert Panel and conducted a systematic review of the medical literature published from September 1,through Octo This review builds on.

The median time to platelet transfusion was 7 days (range platelet count /μL (range 4,/μL); one transfusion did not result in adequate increment while 10 had missing information. Adequate hemostasis was achieved in 50% (3/6) transfusions given due to bleeding. Welcome to the Transfusion Handbook.

5th edition: January PDF version (identical to the printed book) (right click this link and select 'Save Target As ' to download a copy to your pc.). The PDF version is identical to the hard copy of the book. It is fully printable and. Abstract. Aims: This study aimed to estimate the cost of platelet transfusion in patients with chronic liver disease (CLD)-associated thrombocytopenia undergoing an elective procedure in the United States.

Materials and methods: The study was conducted in two parts: development of a conceptual framework identifying direct, indirect and intangible costs of platelet transfusion, followed by the.

Platelet transfusion, also known as platelet concentrate, is used to prevent or treat bleeding in people with either a low platelet count or poor platelet function. Often this occurs in people receiving cancer chemotherapy. Preventive transfusion is often done in those with platelet levels of less than 10 x 10 9 /L.

In those who are bleeding transfusion is usually carried out at less than 50 x ATC code: B05A (WHO). Although platelet transfusion is a vital part of modern hemother- apy, many related issues are unresolved. The most appropriate trigger point for transfusion and the clinical utility of prophylactic transfusion are still debated, but the importance of patient-specific transfusion decisions is clear.

Background: Platelet transfusions are administered to prevent or treat bleeding in patients with quantitative or qualitative platelet disorders.

Description Platelet Transfusions FB2

The AABB (formerly, the American Association of. Prophylactic platelet transfusion involves transfusion prior to thrombocytopenia levels generally requiring therapeutic platelet transfusion. Use of trigger levels for platelet transfusion, different dosage, and varied intervals between transfusions have been studied in patients with cancer for prevention of bleeding.

Platelet transfusions may result in high temperature, rash or itching. In order to reduce the impact of possible side effects, patients are monitored carefully while they are receiving platelet transfusions. If a patient does have an adverse reaction during a transfusion, the treatment is stopped.

Platelet transfusion is indicated for patients with clinically significant bleeding in whom thrombocytopenia is thought to be a major contributory factor, even if the platelet count is >10x/L. In patients with critical bleeding requiring massive blood transfusion.

In these patients, the use.

Details Platelet Transfusions EPUB

Download Platelet Transfusion Therapy full book in PDF, EPUB, and Mobi Format, get it for read on your Kindle device, PC, phones or tablets. Platelet Transfusion Therapy full free pdf books.

(International System of Units) is (number) platelets × /L. Both con-ventions are used in this book, and we have resisted standardization.

This is a multiauthor book because we have considered it the best strategy to ensure that all aspects of platelet transfusion therapy are dis. Platelet transfusion versus no platelet transfusion (1 trial, 72 participants) We were very uncertain whether giving a platelet transfusion prior to surgery had any effect on all-cause mortality within 30 days (1 trial, 72 participants; risk ratio (RR)95% confidence.

Platelet Transfusion Therapy 1st Edition by AABB Press (Author), Joseph y (Editor), MD (Editor), & ISBN ISBN Why is ISBN important. ISBN. This bar-code number lets you verify that you're getting exactly the right version or edition of a book.

Blood transfusion is the process of transferring blood or blood products into one's circulation intravenously.

Transfusions are used for various medical conditions to replace lost components of the blood. Early transfusions used whole blood, but modern medical practice commonly uses only components of the blood, such as red blood cells, white blood cells, plasma, clotting factors, and platelets.

The Blood Book: Australian Blood Administration Handbook is a comprehensive resource to assist with safe bedside transfusion practice.

To order a hard copy, please email [email protected] With great pleasure we present the new online edition of the Canadian Blood Services’ Clinical Guide to Transfusion.

This Guide is an educational resource for health care workers on the provision of blood products and transfusion medicine services in Canada. Introduction. Platelets (PLTs) for transfusion can be collected by apheresis technology or prepared from whole blood.

In the latter case, whether the PLT concentrate is prepared from the buffy coat or from platelet-rich plasma, multiple donor units are pooled together to produce a dose of PLTs that is suitable for transfusion to an adult Without PLT therapy, many modern day treatments would.

Apart from addressing how it is used in a wide array of clinical settings—not only in hematologic malignancies but also in surgery and trauma, platelet dysfunctions, hepatic disease, premature neonates, and others—this book also considers the important question of why, in order to promote appropriate transfusion practice.

The identification of platelets as a distinct cellular element of blood with a critical role in hemostasis in the late s inevitably led to speculation about platelet transfusion as a treatment for bleeding in patients with realization of this goal was delayed for many years by technical barriers.Only use platelet transfusion prior to a procedure or surgery when other treatment has failed and/or the intervention is urgent.

Usual threshold counts may be unachievable or unnecessary and individual case review is required (1C) Give therapeutic platelet transfusions (more than one dose) to .